17 research outputs found
Managing adverse effects of disease-modifying agents used for treatment of multiple sclerosis
No full textInterferon β-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9
No full textPrevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects
No full textIFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response
No full textFrequency and severity of headache is worsened by Interferon-β therapy in patients with multiple sclerosis
No full text
Randomized study of once-weekly interferon β-1a therapy in relapsing multiple sclerosis: three-year data from the OWIMS study
No full textImmunomodulatory treatment of multiple sclerosis in Denmark: a prospective nationwide survey
No full text
